PFIZER stock news
This page provides real-time market news, earnings updates, and company announcements related to PFIZER LIMITED (PFIZER).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-28 06:47 IST
Outlook Therapeutics Drops 45%: What Caused the Sharp Decline?
101 finance2026-03-24 14:18:47
Achieve Life (ACHV) Plunges 20% Intraday: What’s Fueling the Volatility?
101 finance2026-03-24 15:09:53
Pfizer Faces Regulatory Hurdle as $36 Target Hinges on Early Prostate Cancer Label Expansion
101 finance2026-03-24 15:18:35
Pfizer shares climb by 0.71% after exceeding earnings expectations, with increased institutional purchases pushing trading volume to the 108th position
101 finance2026-03-24 22:57:47
Dividend Aristocrats Confront Changing Valuations—Does Johnson & Johnson’s 50% Surge Allow for Any Missteps?
101 finance2026-03-25 00:18:54
Confidential Computing Emerges as Non-Negotiable Rail in AI Infrastructure Buildout
101 finance2026-03-25 01:22:19
Pfizer’s shift toward oncology and investment in GLP-1 therapies may establish a fresh competitive edge—however, the real challenge for their recovery will come with 2026 profit results.
101 finance2026-03-25 06:36:40
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO) for Relapsed/Refractory Multiple Myeloma
Finviz2026-03-25 11:03:55
Corcept Therapeutics Soars: A Remarkable 42% Jump Breaks Expectations
101 finance2026-03-25 15:28:03
Insmed Ignites: Bulls Take Back $147 with a 6% Rally, Defying the Downturn
101 finance2026-03-25 16:54:52
Will BMY's Opdivo's Newly Expanded Label Strengthen Its Immuno-Oncology Portfolio?
101 finance2026-03-25 17:09:51
Geron Announces Appointment of New Members to its Board of Directors
Finviz2026-03-26 12:03:45
Enanta Pharmaceuticals: Why the Patent Appeal Is a Distraction From the RSV Catalyst That Actually Matters
101 finance2026-03-26 13:06:43
Alzamend Neuro in Freefall: A 22% Plunge Shatters $1.93 as Panic Sets In
101 finance2026-03-26 15:15:58
Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
Finviz2026-03-26 20:09:54
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO
Finviz2026-03-26 20:09:55
Why Pfizer (PFE) Rose Even as the Market Declined Today
101 finance2026-03-26 22:48:59
CDT Crashes 24% in Intraday Trading Amid Patent Filing and Market Doldrums — What’s Next?
101 finance2026-03-27 14:07:11
ImmunityBio or Moderna: Which Biotechnology Company Offers Greater Growth Opportunities?
101 finance2026-03-27 14:18:42
Can J&J's New Medications Sustain Its Innovative Medicine Segment After Stelara's Loss of Exclusivity?
101 finance2026-03-27 14:18:52
Astrazeneca Jumps 3.6% on Unexpected Strength — Will the Rally Last?
101 finance2026-03-27 15:03:52
Iterum Therapeutics Plummets 70%: What’s Behind the Freefall in ITRM?
101 finance2026-03-27 15:09:40
Elanco Animal Health Drops More Than 5% – What’s Behind the Abrupt Decline?
101 finance2026-03-27 15:15:58
Mangoceuticals Surges 21.7% on Intraday Rally—What's Fueling This Volatile Move?
101 finance2026-03-27 18:24:46
Dividend Aristocrats Confront Changing Valuations—Does Johnson & Johnson’s 50% Surge Allow for Any Missteps?
101 finance2026-03-25 00:18:54
Confidential Computing Emerges as Non-Negotiable Rail in AI Infrastructure Buildout
101 finance2026-03-25 01:22:19
Pfizer’s shift toward oncology and investment in GLP-1 therapies may establish a fresh competitive edge—however, the real challenge for their recovery will come with 2026 profit results.
101 finance2026-03-25 06:36:40
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO) for Relapsed/Refractory Multiple Myeloma
Finviz2026-03-25 11:03:55
Corcept Therapeutics Soars: A Remarkable 42% Jump Breaks Expectations
101 finance2026-03-25 15:28:03
Insmed Ignites: Bulls Take Back $147 with a 6% Rally, Defying the Downturn
101 finance2026-03-25 16:54:52
Will BMY's Opdivo's Newly Expanded Label Strengthen Its Immuno-Oncology Portfolio?
101 finance2026-03-25 17:09:51
Geron Announces Appointment of New Members to its Board of Directors
Finviz2026-03-26 12:03:45
Enanta Pharmaceuticals: Why the Patent Appeal Is a Distraction From the RSV Catalyst That Actually Matters
101 finance2026-03-26 13:06:43
Alzamend Neuro in Freefall: A 22% Plunge Shatters $1.93 as Panic Sets In
101 finance2026-03-26 15:15:58
Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
Finviz2026-03-26 20:09:54
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO
Finviz2026-03-26 20:09:55
Why Pfizer (PFE) Rose Even as the Market Declined Today
101 finance2026-03-26 22:48:59
CDT Crashes 24% in Intraday Trading Amid Patent Filing and Market Doldrums — What’s Next?
101 finance2026-03-27 14:07:11
ImmunityBio or Moderna: Which Biotechnology Company Offers Greater Growth Opportunities?
101 finance2026-03-27 14:18:42
Can J&J's New Medications Sustain Its Innovative Medicine Segment After Stelara's Loss of Exclusivity?
101 finance2026-03-27 14:18:52
Astrazeneca Jumps 3.6% on Unexpected Strength — Will the Rally Last?
101 finance2026-03-27 15:03:52
Iterum Therapeutics Plummets 70%: What’s Behind the Freefall in ITRM?
101 finance2026-03-27 15:09:40
Elanco Animal Health Drops More Than 5% – What’s Behind the Abrupt Decline?
101 finance2026-03-27 15:15:58
Mangoceuticals Surges 21.7% on Intraday Rally—What's Fueling This Volatile Move?
101 finance2026-03-27 18:24:46
PFIZER stock price change
On the last trading day, PFIZER stock closed at 4692.00 INR, with a price change of -0.37% for the day.
Trade stock perpsPFIZER stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more